Light-controlled inhibition of malignant glioma by opsin gene transfer |
| |
Authors: | F Yang J Tu J-Q Pan H-L Luo Y-H Liu J Wan J Zhang P-F Wei T Jiang Y-H Chen L-P Wang |
| |
Affiliation: | 1.Shenzhen Key Lab of Neuropsychiatric Modulation, Research Centre for Neural Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Xili Nanshan, Shenzhen, China;2.Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China;3.Department of Pathology and Laboratory Medicine, School of Medicine, University of Pennsylvania, Philadelphia, PA, USA |
| |
Abstract: | Glioblastomas are aggressive cancers with low survival rates and poor prognosis because of their highly proliferative and invasive capacity. In the current study, we describe a new optogenetic strategy that selectively inhibits glioma cells through light-controlled membrane depolarization and cell death. Transfer of the engineered opsin ChETA (engineered Channelrhodopsin-2 variant) gene into primary human glioma cells or cell lines, but not normal astrocytes, unexpectedly decreased cell proliferation and increased mitochondria-dependent apoptosis, upon light stimulation. These optogenetic effects were mediated by membrane depolarization-induced reductions in cyclin expression and mitochondrial transmembrane potential. Importantly, the ChETA gene transfer and light illumination in mice significantly inhibited subcutaneous and intracranial glioma growth and increased the survival of the animals bearing the glioma. These results uncover an unexpected effect of opsin ion channels on glioma cells and offer the opportunity for the first time to treat glioma using a light-controllable optogenetic approach. |
| |
Keywords: | gene therapy cancer channelrhodopsin optogenetic glioma |
|
|